Ingredient
Bimatoprost
Bimatoprost is flagged for pregnancy, breastfeeding, trying to conceive and general use. The concern behind the strongest flag is fetal development and absorbed into the body.
- Lumigan
- Latisse
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 4 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 3 of 5
- Higher means more likely to sting or redden
Bimatoprost and pregnancy
Not Recommended
- Fetal development
- Absorbed into the body
Bimatoprost is a synthetic prostaglandin analog used medically for glaucoma treatment and cosmetically for eyelash enhancement. When applied to the eye area, it has measurable systemic absorption. The FDA classifies bimatoprost as Pregnancy Category C, meaning animal studies have shown adverse effects on the fetus, but adequate human studies are lacking. Animal studies demonstrated increased incidences of abortion and fetal abnormalities at doses above therapeutic levels. Prostaglandins can affect uterine contractility and potentially influence pregnancy outcomes. According to ACOG and most ophthalmologists, prostaglandin analogs should be avoided during pregnancy unless the medical benefit clearly outweighs potential fetal risks. The FDA and medical professionals recommend discontinuing bimatoprost during pregnancy, particularly for cosmetic eyelash enhancement purposes. Pregnant women requiring glaucoma treatment should consult their ophthalmologist about safer alternatives during pregnancy.
Bimatoprost and breastfeeding
Not Recommended
- Passes into breast milk
- Infant exposure
Bimatoprost is a prostaglandin analog that can be systemically absorbed from ocular application. While specific data on breast milk transfer is limited, the medication's lipophilic nature suggests potential for milk passage. The American Academy of Pediatrics and most ophthalmologists recommend avoiding bimatoprost during breastfeeding due to insufficient safety data and potential infant exposure. Prostaglandin analogs theoretically could affect the breastfed infant, though no specific cases of harm have been documented. Given its use is often cosmetic (eyelash growth) rather than medically necessary, the risk-benefit ratio favors discontinuation. Breastfeeding mothers should avoid using bimatoprost for cosmetic purposes and discuss alternative glaucoma treatments with their ophthalmologist if medical use is required. Most dermatologists recommend waiting until after weaning to resume eyelash enhancement treatments.
Bimatoprost and postpartum
Safe to Use
- Irritant
Bimatoprost can be resumed for eyelash enhancement or glaucoma treatment after pregnancy when not breastfeeding. The ingredient's pregnancy-related concerns no longer apply once pregnancy and breastfeeding have concluded. Women should be aware of the cosmetic side effects, including potential iris darkening, periorbital fat loss, and skin hyperpigmentation with long-term use. These effects can alter facial appearance but are not health concerns. Consultation with a healthcare provider is recommended before resuming use.
Bimatoprost and trying to conceive
Not Recommended
- Fetal development
Bimatoprost is FDA Pregnancy Category C and should be discontinued when actively trying to conceive. While the ingredient's effects on early pregnancy are not fully characterized, its potential to affect uterine contractility and the documented animal fetal effects warrant caution. Most reproductive endocrinologists and ophthalmologists recommend stopping bimatoprost before attempting conception, particularly when used cosmetically for eyelash enhancement. Women requiring the medication for glaucoma should discuss timing and alternatives with their healthcare team.
Bimatoprost and PCOS
Safe to Use
Bimatoprost is a prostaglandin analog used for eyelash growth enhancement and glaucoma treatment. It does not have hormonal activity or effects on androgen or estrogen pathways. There is no evidence that bimatoprost affects PCOS symptoms or interferes with hormonal balance. The medication works through prostaglandin receptors and does not impact insulin sensitivity or reproductive hormones. Women with PCOS can safely use bimatoprost for its intended purposes. The ingredient does not interfere with PCOS management or hormonal treatments.
Bimatoprost and general use
Caution Advised
- Irritant
Bimatoprost is a prescription medication approved for glaucoma treatment and eyelash hypotrichosis (sparse eyelashes). It works by mimicking natural prostaglandins to increase eyelash growth and lower intraocular pressure. Common side effects include eye irritation, redness, itching, and darkening of the eyelid skin. Long-term cosmetic use can cause periorbital fat atrophy (sunken appearance around eyes) and permanent iris color changes (brown pigmentation). These cosmetic effects are irreversible in some cases. The FDA requires prescription supervision for bimatoprost use. While effective for its intended purposes, users should be aware of potential permanent cosmetic changes and discuss risks and benefits with a healthcare provider.
Everything else flagged for the same profiles
Related ingredients
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store